for asset allocators to unlisted investments
Health
Schroders Capital accelerates UK VC strategy
Head of UK venture talks to PMP about the manager’s aim of channelling DC pension capital into high-growth technology and life sciences companies.
Dementia Discovery Fund 2 achieves final close
SV Health Investors’ second dementia-focused fund secures commitments of $269 million